Coverage of our peer-reviewed research in the healthcare and mainstream press.
A Patient Engagement HIT article highlighted a Letter to the Editor published in the most recent issue of The American Journal of Managed Care® (AJMC®). In the letter, titled “Patient-Centered Care: Turning the Rhetoric Into Reality,” the authors discussed insights from their interviews with 15 leaders of accountable care organizations (ACOs). The Patient Engagement HIT article said that these interviews “revealed a disconnect between practical patient engagement efforts and those called for by policymakers.”
Sarah C. Threnhauser, MPA, began an executive briefing for OPEN MINDS by declaring, “Here is something I’ve long believed: consumer experience in healthcare matters more than anyone suspects.” She then cited “Drivers of Patient Experience in Medicaid Managed Care,” an AJMC® article by contributor Jeff Blake, MBA. Threnhauser wrote that Blake’s piece “gave real credence to this idea—showing the connection between a positive customer experience and the bottom line.”
HealthPayer Intelligence published a list of “Top 3 Reasons to Partner With Accountable Care Organizations” that referenced an Evidence-Based Diabetes Management™ article, “Diabetes Educators in Accountable Care Organizations: Meeting Quality Measures Through Diabetes Self-Management Education and Care Coordination.” According to the list, the study indicated that “ACOs and primary care centers can use Diabetes Self-Management Education to teach patients to incorporate a healthy diet, medication management techniques, physical fitness, and disease monitoring.”
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More